[Cognitive impairment in patients with diabetes mellitus type 2 and possibilities of its treatment].
OBJECTIVE
To identify the most frequently affected cognitive functions and to study the efficacy of Ginkgo biloba (EGb 761).


METHODS
We examined 120 patients with diabetes mellitus type 2. To assess cognitive dysfunction, we used MMSE, MoCa test, TMT (Part A and B).


CONCLUSIONS
Cognitive impairment characterized by a decrease in attention, short-term memory, speed of thinking was identified in 85% of patients; 83% of them had a mild cognitive impairment. The study showed that the standardized extract of Ginkgo biloba (EGb 761) used in dose 240 mg per day during one month had a positive effect on cognitive function.
I Kh
IKh
Khaĭrullin
R G
RG
Esin
A O
AO
Pozdniak
D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D060825:Cognitive Dysfunction / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000523:psychology*; D005260:Female; D020441:Ginkgo biloba; D006801:Humans; D008297:Male; D008570:Memory, Short-Term / Q000187:drug effects; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D000096983:Ginkgo Extract
D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract